水凝胶间隔物降低前列腺癌放疗后放射性直肠炎的大规模理赔数据库分析
PURPOSE: We evaluated the real-world utility of hydrogel spacer placement for reducing radiation proctitis following prostate cancer radiation therapy using a large-scale claims database.…
要点
- 水凝胶间隔物与内镜下止血风险降低相关(sHR 0.26)。
- 间隔物组36个月累积内镜止血发生率为0.8%,非间隔物组为2.3%。
- 间隔物组放射性直肠炎诊断风险亦显著降低(sHR 0.29)。
核心结论
- 大规模真实世界分析表明水凝胶间隔物置入与需内镜止血的严重放射性直肠炎发生率显著降低相关。
研究设计与样本
- 采用平均处理效应(ATT)倾向评分加权平衡间隔物使用者与非使用者的基线特征,并以死亡为竞争风险使用Fine-Gray模型估计亚分布风险比(sHR)。
主要发现
- 7860例可评估患者中1754例(22.3%)置入水凝胶间隔物。
关键数值与推荐
- 主要终点为内镜下胃肠道止血的发生,次要终点为放射性直肠炎的诊断。
临床怎么用
- 在前列腺癌放疗中置入水凝胶间隔物可能降低需内镜止血的严重放射性直肠炎风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the real-world utility of hydrogel spacer placement for reducing radiation proctitis following prostate cancer radiation therapy using a large-scale claims database. METHODS AND MATERIALS: We analyzed male patients from a Japanese administrative claims database (DeSC Database) who initiated primary radiation therapy between July 2018 and December 2024. Propensity score weighting using the average treatment effect on the treated method was applied to balance baseline characteristics between spacer users and nonusers. The primary endpoint was the occurrence of endoscopic gastrointestinal hemostasis, and the secondary endpoint was the diagnosis of radiation proctitis. Fine-Gray models were used to estimate subdistribution hazard ratios (sHRs) with death as a competing risk. RESULTS: Of 7860 eligible patients, 1754 (22.3%) underwent spacer placement. For the primary endpoint (endoscopic hemostasis), the spacer group showed a statistically significant lower risk (sHR 0.26; 95% CI, 0.10-0.69; P = .007). The cumulative incidence at 36 months was 0.8% in the spacer group versus 2.3% in the nonspacer group. For the secondary endpoint (diagnosed proctitis), the sHR was 0.29 (95% CI, 0.16-0.53; P < .001), with a 36-month cumulative incidence of 1.4% versus 4.8%, respectively. CONCLUSIONS: This large-scale real-world analysis demonstrates that hydrogel spacer placement is associated with a significantly lower incidence of severe radiation proctitis requiring endoscopic hemostasis.
引用
- Takeda K, Okuda S, Umezawa R, et al. Impact of Hydrogel Spacer on Radiation Proctitis After Prostate Cancer Radiation Therapy: A Large-Scale Claims Database Analysis. Adv Radiat Oncol. 2026. PMID: 42604081. doi:10.1016/j.adro.2026.102145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。